| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.46 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |